Mohammad AskarPublic working copy · medical review pending

Vitreous and vitreoretinal interface · 185

Vitreous, vitreoretinal interface and retinal drug toxicity

Separate an acute retinal-break risk from chronic interface disease and medicine-related outer retinal injury.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Examine the retinal periphery urgently when symptoms suggest a new break. Use OCT morphology with symptoms and function, and confirm suspected toxicity before coordinated treatment changes.

Terminology and draft status

Terminology review is not complete. No new WHO UMD entry verification is claimed for this copy; pending entries and limits are recorded in terminology.md.

01Understand attachment before interpreting separation

The vitreous base straddles the ora serrata and has particularly strong attachment. The original3–4mm posterior extent is an approximation, not a universal surgical boundary. Adhesion also occurs at the disc, macula, vessels and posterior lens region. During surgery minimise traction with controlled cutting and visualization; shaving is not permission to manipulate the base without risk. 1

Wieger’s hyaloideocapsular ligament links the anterior vitreous/lens region; vitreous prolapse after cataract surgery depends on capsular, zonular and anterior hyaloid integrity, not ligament injury alone. Ageing produces liquefaction (synchysis) and collagen aggregation/collapse (syneresis). Posterior vitreous detachment (PVD/HGA) occurs when separation and adhesion change; liquefaction alone does not prove complete PVD. 1

02Assess acute PVD for breaks before setting follow-up

A Weiss ring supports separation at the disc but does not prove release of every peripheral or macular attachment. Shafer pigment (tobacco dust) and vitreous haemorrhage substantially increase concern for a retinal break; absence of pigment does not exclude one. Examine the dilated peripheral retina with appropriate indirect/contact-lens methods and scleral depression when safe. Indentation improves the view but should not be described as deliberately forcing tears open. 1

If blood or other opacity prevents an adequate view, use B-scan to look for detachment and other pathology. A negative ultrasound cannot reliably exclude every small tear, so repeat examination and specialist planning remain necessary. The quoted50–70% tear risk with haemorrhagic PVD depends on the series and is not a personal probability. New or worsening symptoms need immediate reassessment. 1

The original3–4week uncomplicated and1–2week haemorrhagic follow-up intervals apply only after an adequate initial assessment, not as permission to delay the first examination. Risk and visibility may require earlier or repeated review; the indexed AAO2024 summary describes weekly review for vitreous haemorrhage until resolution. This is a dated example, not a verified current complete PPP schedule for every eye. 1 2

03Connect interface anatomy with symptoms and function

An epiretinal membrane (ERM/gliose) contains proliferating cells and matrix and is not explained by hyalocytes alone. Assess distortion, reading, acuity, lens and OCT together before observation or PPV with membrane peeling. The original acuity≤0.5 (5/10) is not a mandatory surgical threshold; a symptomatic eye above it may benefit and an eye below it may have other reasons for poor vision. 1

Vitreomacular adhesion (VMA) leaves foveal structure undisturbed; VMT distorts it. A hyperreflective cotton-ball sign is not a hyporeflective pseudocyst or a validated predictor that a macular hole is imminent. The original cotton-ball/bouquet reports were selected retrospective series; they do not supply a general future-hole probability. Symptoms, morphology and course guide treatment. 1 3 4

In two randomized double-blind MIVI-TRUST trials,652treated eyes received ocriplasmin464 or placebo188. Adhesion release at day28 was26.5% versus10.1%; this explains the original rounded26% but is not success for all VMT or a guarantee of visual recovery. Trial selection, short anatomical endpoint, adverse visual/outer-retinal effects and current local availability matter. The quoted$4000 lacks date/jurisdiction and does not establish cost-effectiveness. 1 5

Pneumatic vitreolysis uses gas such as SF6/C3F8 without full vitrectomy; it can release traction but can also cause tears, detachment or a hole and is not a routine cheap substitute. PPV is established for selected symptomatic persistent VMT, not mandatory for every adhesion. Explain gas-related restrictions, positioning and emergency access if gas is used. 1

04Describe a macular hole with the actual classification

Historical Gass stages and OCT size classes are not interchangeable. A stage0 risk configuration is not synonymous with every VMA; stage1 is an impending foveal change without a full-thickness hole. Stages2/3/4 combine hole size and vitreous status; the export’s<400/>400µm shorthand omits boundary and attachment detail. IVTS describes small≤250µm, medium>250–≤400µm and large>400µm, plus primary/secondary cause and VMT status. 1 6

PPV, release of residual traction, usually ILM peeling and selected gas such as SF6 form an established repair strategy. Size, symptom duration, outer retinal integrity and previous repair influence closure and vision separately. The original4–6month duration is a prognostic warning, not a universal deadline after which repair is futile. Anatomical closure does not guarantee normal visual recovery. 1

05Evaluate developmental remnants without missing malignancy

Mittendorf’s dot at the posterior lens and Bergmeister’s papilla at the disc are often benign remnants of the fetal hyaloid system. Persistent fetal vasculature (PFV, formerly persistent fetal vitreous) can include an anterior retrolental membrane, shallow chamber and microphthalmia, or a posterior stalk with traction. Describe the actual anterior/posterior extent; no single remnant is pathognomonic for the complete syndrome. 1

Select observation versus lensectomy/vitrectomy according to anatomy, visual potential, traction and complications. Posterior PFV does not automatically require lensectomy or silicone oil; the quoted70% success lacks the endpoint and case series. Leukocoria needs urgent differentiation from retinoblastoma: microphthalmia favours PFV and a normal-sized eye can carry RB, but size alone cannot safely distinguish them. 1

06Interpret particles and choose useful imaging

Asteroid hyalosis contains refractile calcium/phosphate and lipid-associated bodies. A small human ultrastructural series supports this composition; the export’s Kalzium-Lepidopteren is not an established composition term. Many patients retain useful vision despite a difficult fundus view, but visually significant cases occur. Synchysis scintillans contains mobile cholesterol crystals that settle inferiorly, often after prior ocular pathology or haemorrhage; it is a different process. 1 7

Choose OCT, ultrasound or angiography to answer the suspected retinal problem and available view. FA may reveal vascular disease through asteroid bodies, but it is not a universal imaging gold standard or an internal light source that escapes scattering. Reassess function and other pathology before observation or selected vitrectomy; poor examiner visibility and good patient acuity are not a physical guarantee of a healthy retina. 1

07Screen for toxicity and coordinate a confirmed finding

HCQ can damage parafoveal or pericentral outer retina; the flying-saucer sign reflects foveal sparing, not a required early finding. The AAO2025revision/2026 approach uses OCT with wide-pattern FAF as primary tests, with visual fields/mfERG to confirm uncertain findings. Look for both patterns regardless of ancestry; choose10-2, wider24-2/30-2 or combined24-2C by the area needing assessment, not a mandatory test solely from ethnicity. 1 8

Obtain a baseline close to starting HCQ and plan annual screening; low-risk patients may defer routine annual testing during the first5years, while significant risk requires earlier review. Daily dose≤5mg/kg real body weight, duration, renal disease and tamoxifen influence risk; no dose is a safety guarantee. The separate German S1July2025 source-image discrepancy remains open and is not silently harmonised into the AAO protocol. 1 8

Tamoxifen can cause crystals and foveal cavitation resembling MacTel2; this is not always leaking oedema. Pentosan polysulfate (PPS), used for bladder pain/interstitial cystitis, can cause a pigmentary maculopathy resembling AMD. MEK inhibitors may cause multifocal serous changes, which need distinction from CSC and inflammatory disease. Exposure, timing and alternative diagnoses matter before labelling drug toxicity. 1 8

Repeat/corroborate uncertain abnormalities and discuss the systemic benefit with the prescriber before stopping treatment. Mild HCQ injury may stabilise after withdrawal; advanced outer-retinal/RPE damage may progress for years. No unsupervised withdrawal or inevitable progression in every eye is justified. Agree documentation, communication and individualized follow-up. 1 8

Screen for toxicity and coordinate a confirmed finding
ConditionFindingManagementBoundary
Acute PVDWeiss ring, flashes or pigmentUrgent peripheral retinal examinationHaemorrhage raises risk;50–70% not universal, no delayed first assessment
ERMDistortion, wrinklingSelected PPV/peeling by function and symptoms≤0.5acuity is not a universal indication
VMTFoveal traction/cystsSelected observation/PPV;other options restrictedOcriplasmin26%quoted;trial26.5%/10.1%, cost/current availability uncertain;gas risks
Macular holeFull-thickness foveal defectPPV±ILM peeling/selected SF6>4–6months is a risk context, not inevitable failure
PFVLeukocoria, microphthalmia, stalkSelected lensectomy/vitrectomy or observation70%success/oil not universal;excludeRB
HCQ toxicityOuter-retinal pattern/flying-saucer signConfirm findings, coordinate prescription review10-2or24-2/30-2by pattern, not ancestry alone
Asteroid hyalosisRefractile calcium-associated particlesOften observation, imaging selected to questionFA not universally best or free of scatter;patient may still be symptomatic
What are the main learning points?

Examine the retinal periphery urgently when symptoms suggest a new break. Use OCT morphology with symptoms and function, and confirm suspected toxicity before coordinated treatment changes.

When is assessment urgent?

New flashes, floaters, a curtain or rapid visual loss needs urgent retinal assessment. Leukocoria in a child needs prompt evaluation including exclusion of retinoblastoma.

References and access status

  1. 1
    Immutable original export; vitreous/interface/toxicology lecture; own question/patient/video identity retained

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    AAO Retina Summary Benchmarks, December2024, selected PVD follow-up

    Selected indexed follow-up text inspected16November2026; not current fullPPP. Direct2025summary request403, not read afresh.

  3. 3
    Cotton-ball sign2012, PMID22115711

    Historical016 selected retrospective primary abstract/first-page appraisal reused, not new full report.

  4. 4
    Central foveal bouquet/ERM2018, PMID29106913

    Historical016primary abstract appraisal reused; not validated future-hole prediction/full report.

  5. 5
    MIVI-TRUST ocriplasmin randomized trials2012, PMID22894573

    Selected actual indexed methods/results inspected16November2026: two double-blind trials652treatedeyes, day28anatomical endpoint; full report/protocol/current labels not appraised.

  6. 6
    IVTS classification2013, PMID24053995

    Historical015primary abstract/selected classification/table appraisal reused with original boundary discrepancy; no fresh full report.

  7. 7
    Streeten1982, ultrastructure of asteroid bodies, PMID7092637

    Actual indexed primary abstract read16November2026; five human cases, element/electron studies support composition, not treatment or population prognosis.

  8. 8
    AAO HCQ2025revision/2026 statement

    Historical180selected actual indexed recommendations read16November2026 reused; no new full-report/image/label/whole GermanS1 concordance.

Original lecture link